Immunotherapy-chemo combo extends life for women with aggressive form of breast cancer, study finds

It's good news for women with triple-negative breast cancer, an aggressive and hard-to-treat form of breast ...

Posted: Oct 22, 2018 11:36 PM
Updated: Oct 22, 2018 11:36 PM

It's good news for women with triple-negative breast cancer, an aggressive and hard-to-treat form of breast cancer that targets women under 50.

A new study published Saturday in the New England Journal of Medicine found a combination of chemotherapy and antibody medications taught the women's own immune system to attack cancer cells, in some cases extending life by almost a year.

Breast cancer

Cancer

Chemotherapy and radiation treatments

Demographic groups

Diseases and disorders

Females (demographic group)

Health and medical

Medical fields and specialties

Medical treatments and procedures

Oncology

Population and demographics

Society

"This is the first time immunotherapy has worked in such a difficult to treat cancer, and is a huge step forward for these breast cancer patients," said lead author Dr. Peter Schmid of Queen Mary University of London, in a statement. He presented his findings at the European Society for Medical Oncology conference in Munich, Germany on Saturday.

"This is a real advance that is going to allow us to help more people," said Memorial Sloan Kettering oncologist Dr. Larry Norton, who was not involved in the study. "Once we get regulatory approval, I think the expectation is this will change the standard of care."

Triple-negative breast cancer

About one in ten of all breast cancers are triple-negative, according to the National Breast Cancer Foundation. It is most likely to affect Hispanic and African American women and those with a BRCA1 gene mutation. It also tends to attack women in their 40s and 50s.

"It is particularly tragic that those affected are often young," Schmid said, and likely to still be raising families. "We have desperately been looking for better treatment options."

When breast cancer cells test negative for estrogen, progesterone, or human epidermal growth factor 2 (HER2), it's called a triple-negative breast cancer. Therefore, it does not respond to any of the available hormonal cancer treatments.

It does respond to chemotherapy. However, for most women the cancer cells quickly develop resistance to the chemo. That allows the aggressive cancer to spread to other parts of the body, thus reducing survival rates.

In this trial, the combination of medication and chemo extended overall survival by 10 months for some women, the study found. The chance of the cancer spreading to other areas of the body and the risk of death was also reduced by up to 40%.

"This is just the beginning of using immunotherapy for breast cancer," said Norton who serves as the director of the Evelyn H. Lauder Breast Center at the Memorial Sloan Kettering Cancer Center.

Scientists are learning "so much and so rapidly about other ways to stimulate the immune system," Norton said, that he predicts an "explosion of well-designed studies that will push the agenda forward."

How does it work?

The new treatment combines the immunotherapy drug atezolizumab and traditional chemotherapy.

In a normal state, the immune system will not attack cancer cells because they are viewed as a part of the body. That's where atezolizumab comes in. It's an antibody that attaches to the cancer cell. It's job is to inactivate a protein called PD-L1, which is responsible for telling the immune system "don't attack me."

Chemotherapy is also needed, to "rough up" the exterior of the cancer cell, Schmid explained. That allows the newly revved-up immune system to recognize and attack the invader.

"We are using chemotherapy to tear away the tumor's 'immune-protective cloak,' to expose it," Schmid said, "enabling people's own immune system to get at it."

The Phase three study followed more than 900 women enrolled at 246 sites in 41 countries, who were randomly assigned to receive atezolizumab and chemo, or a placebo and chemo.

Standard chemotherapy was given every week. Atezolizumab was given intravenously every two weeks.

At least half of the women who tested positive for the protein PD-L1 lived another 7.5 months with no progression of cancer when on the combination of immunotherapy and chemo. That's about two months longer than PD-L1-positive or -negative women using chemotherapy and a placebo.

"We are particularly encouraged by the fact some patients are living without recurrence for an extended period of time," said Norton. "Finding out why those patients do so much better than others is going to be one of the important topics for future research."

The trial was funded by Roche, the maker of atezolizumab.

Mississippi Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 14372

Reported Deaths: 693
CountyConfirmedDeaths
Hinds92024
Lauderdale69957
Madison68721
Scott62310
Neshoba56534
Jones52519
Forrest51137
DeSoto4936
Leake39512
Rankin3736
Holmes37324
Jackson30013
Copiah2854
Attala27715
Monroe25324
Leflore25030
Lincoln25022
Newton2504
Harrison2457
Lamar2275
Yazoo2233
Pearl River20731
Pike20211
Adams19015
Lowndes1828
Noxubee1696
Washington1636
Warren1587
Oktibbeha15010
Bolivar14911
Wayne1480
Jasper1483
Covington1411
Clarke13517
Smith13311
Kemper13110
Chickasaw12812
Lafayette1254
Lee1175
Carroll11410
Coahoma1133
Marion1129
Winston1051
Clay1043
Lawrence991
Simpson930
Hancock8711
Yalobusha855
Wilkinson859
Itawamba857
Grenada823
Montgomery811
Sunflower783
Union785
Marshall763
Jefferson Davis752
Tippah7111
Tate691
Panola643
Claiborne642
Calhoun614
Webster591
Amite561
Humphreys537
Tunica523
Walthall510
Perry492
Prentiss413
Jefferson400
Choctaw352
Stone300
Pontotoc283
Franklin272
Tishomingo260
Quitman250
Tallahatchie251
George201
Benton140
Alcorn141
Greene111
Sharkey70
Unassigned00

Alabama Coronavirus Cases

Confirmed Cases: 16310

Reported Deaths: 590
CountyConfirmedDeaths
Mobile2085112
Jefferson167397
Montgomery144634
Marshall6609
Tuscaloosa63212
Lee52632
Franklin4986
Shelby47019
Tallapoosa41063
Butler39113
Chambers34024
Madison3154
Elmore3007
Baldwin2829
Walker2821
DeKalb2403
Etowah24011
Dallas2323
Coffee2191
Lowndes21610
Morgan2111
Sumter2106
Autauga1923
Houston1854
Bullock1763
Pike1730
Colbert1612
Calhoun1523
Marengo1506
Choctaw1487
Russell1480
Lauderdale1452
Hale1416
Wilcox1327
Barbour1301
Clarke1282
Randolph1247
Marion11711
St. Clair1081
Pickens964
Dale960
Talladega963
Chilton931
Greene914
Cullman880
Limestone860
Winston770
Covington751
Jackson742
Bibb711
Henry702
Macon672
Crenshaw662
Washington656
Blount531
Escambia483
Lawrence460
Geneva400
Perry360
Conecuh351
Coosa341
Monroe342
Cherokee332
Clay272
Lamar210
Cleburne131
Fayette130
Unassigned00
Tupelo
Clear
70° wxIcon
Hi: 84° Lo: 63°
Feels Like: 70°
Columbus
Few Clouds
74° wxIcon
Hi: 85° Lo: 63°
Feels Like: 74°
Oxford
Clear
66° wxIcon
Hi: 77° Lo: 61°
Feels Like: 66°
Starkville
Scattered Clouds
72° wxIcon
Hi: 83° Lo: 60°
Feels Like: 72°
WTVA Radar
WTVA Temperatures
WTVA Severe Weather